This site is intended for heath plan professionals in Canada.

This site is intended for health plan professionals in Canada.

U.S. professionals should visit ManagedCareCGM.com

Continuous Glucose Monitoring

Continuous Glucose Monitoring - CGM

Insights & Education for Health Benefit Plan Professionals in Canada

Next-Generation Dexcom G7 CGM
System Approved by Health Canada

CanadaCGM.com Expert Interview with
Michael C. Riddell, PhD



Suzanne Lepage, a private health plan strategist with over 20 years in the
group insurance industry, is joined by Michael C. Riddell, PhD, Professor,
School of Kinesiology and Health Science, Faculty of Health, York University
diabetes registry recently published in Diabetic Medicine.

Coverage Update


          All NIHB Plan Members Ages 2 Years and Older
          Managing their Type 1 and Type 2 Diabetes with Insulin
          are Eligible for Dexcom G6 Coverage

Cost-effectiveness of Real-Time Continuous Glucose Monitoring

Key findings from a cost-effectiveness analysis (CEA) for adults with insulin-treated
type 2 diabetes in Canada suggests the use of Dexcom G6 Real-Time Continuous Glucose
Monitoring (rtCGM) provides a cost-effective disease management option relative to
SMBG. The CEA is built on data from the growing body of evidence that shows rtCGM
to be transformative for many people living with diabetes.

Featured Article

CGM use Lowers Hospitalizations, may Reduce Mortality in Type 1 and Type 2 Diabetes

New Video Resource

ADA 2023 Highlights: The Clinical and Economic Value of CGM

Watch Now

Featured Update

2021 Update from the Diabetes Canada Clinical Practice Guidelines
Expert Working Group on Blood Glucose Monitoring
in Adults and Children with Diabetes

Evidence-Based Rationale for Expanding Access to CGM in Individuals with Type 2 Diabetes Treated with Nonintensive Therapies

Evidence-Based Rationale for Expanding Access to CGM in Individuals with Type 2 Diabetes Treated with Nonintensive Therapies – Diabetes Technology & Therapeutics – August 2023

Read More

Large, Single-Center Study Shows that Increased Utilization of Technology Significantly Improved Glycemic Outcomes in Type 1 Diabetes

Large, Single-Center Study Shows that Increased Utilization of Technology Significantly Improved Glycemic Outcomes in Type 1 Diabetes – American Diabetes Association – July 17, 2023

Read More

Next-Generation Dexcom G7 CGM System Approved by Health Canada

Next-Generation Dexcom G7 CGM System Approved by Health Canada – Business Wire – July 4, 2023

Read More

At Home Use of Closed Loop Insulin System in Pregnancy Determined to be Feasible

At Home Use of Closed Loop Insulin System in Pregnancy Determined to be Feasible – Diabetes Care – May 17, 2023

Read More

A review of the symposium: “Eureka Moments: How Real-time Continuous Blood Glucose Monitoring (rtCGM) Has Changed Our Practice”

A review of the Symposium: “Eureka Moments: How Real-Time Continuous Blood Glucose Monitoring (rtCGM) has Changed Our Practice”  – The Diabetes Communicator (Page 11) – Winter 2023

Read More

Disparities in Hemoglobin A1C in the First Year After Diagnosis Among Youths with Type 1 Diabetes Offered Continuous Glucose Monitoring

Disparities in Hemoglobin A1c in the First Year After Diagnosis Among Youths with Type 1 Diabetes Offered Continuous Glucose Monitoring – JAMA – April 19, 2023

Read More

Mednow Launches New Virtual Diabetes Management Program in Partnership With Dexcom

Mednow Launches New Virtual Diabetes Management Program in Partnership with Dexcom –The Globe and Mail – February 2, 2023

Read More

CanadaCGM.com Expert Interview with Michael C. Riddell, PhD

CanadaCGM.com Expert Interview with Michael C. Riddell, PhD – CanadaCGM – January 10, 2023

Read More

CanadaCGM.com Expert Interview with Dr. Alexander Abitbol, MDCM, FRCPC

CanadaCGM.com Expert Interview with Dr. Alexander Abitbol, MDCM, FRCPC – CanadaCGM – December 14, 2022

Read More

ADA 2022: Spotlight on Real-World Evidence Supporting the Use of Real-Time Continuous Glucose Monitoring – CanadaCGM – November 2, 2022

ADA 2022: Spotlight on Real-World Evidence Supporting the Use of Real-Time Continuous Glucose Monitoring – CanadaCGM – November 2, 2022

Read More